Detecting Toxic Myopathies as Medication Side Effect.

Authors

Elba Gerena-Maldonado, Department of Physical Medicine and Rehabilitation, Providence St. Joseph Health, Providence Medical GroupFollow

Document Type

Article

Publication Date

11-1-2018

Keywords

Electrodiagnostic studies; Muscle biopsy; Muscle weakness; Rhabdomyolysis; Toxic myopathy; Biopsy; Drug-Related Side Effects and Adverse Reactions/diagnosis; Electrodiagnosis; Humans; Magnetic Resonance Imaging; Muscular Diseases/chemically induced; Muscular Diseases/diagnosis

Abstract

The goal of this article is to provide physiatrists, neurologists, and neuromuscular medicine physicians a framework that can be easily used in the process of evaluating, identifying, and treating patients with toxic myopathies. This review attempts to classify these rare but potentially deadly conditions in clinical patterns and distinguishes the cellular mechanisms in which the offending agents tend to impact the structure and function of myocytes.

Clinical Institute

Neurosciences (Brain & Spine)

Department

Rehabilitation

Department

Neurosciences

Recommended Citation

Gerena-Maldonado, Elba, "Detecting Toxic Myopathies as Medication Side Effect." (2018). Articles, Abstracts, and Reports. 797.
https://digitalcommons.providence.org/publications/797